SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

TLRY is trending as traders discuss Trump's potential executive action to reclassify marijuana, sparking hope for the cannabis sector. The community is debating the implications of rescheduling, potential short squeezes, and comparing TLRY to other cannabis stocks. Some are also expressing skepticism, citing past disappointments and the need for concrete action.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom's stock is experiencing volatility despite strong earnings, with analysts' target prices driving much of the current discussion. While the company beat expectations and offered positive guidance, some investors are taking profits, and others are concerned about future growth potential in non-AI sectors. The community is debating the sustainability of Broadcom's valuation and the impact of AI revenue projections.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending as the community discusses recent investments in Ukrainian drone technology and potential benefits from increased defense spending. Bullish sentiment is fueled by the company's growing presence in the drone and counter-drone space, with speculation around upcoming announcements and price target increases. Traders are actively monitoring key price levels for breakout opportunities, and whether it could trigger a short squeeze.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is gaining significant traction, fueled by community enthusiasm and its association with the Ethereum ecosystem. Discussions highlight its potential as a leading meme token and a beneficiary of renewed interest in ETH, with some even suggesting it could be the next PEPE. The community emphasizes strong fundamentals, a compelling narrative, and increasing accumulation from experienced traders.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending as it approaches 52-week lows, with community members debating whether it's a value trap or a buying opportunity amid analyst downgrades and concerns about competition. Some traders are attributing the decline to tax-loss harvesting, while others speculate about a potential acquisition or removal from the Nasdaq 100. Despite the bearish sentiment, some investors believe the long-term fundamentals remain strong and are accumulating shares, anticipating a rebound in 2026.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending due to significant intraday volatility, with community members actively discussing a potential short squeeze and the impact of a recent conference. The stock's price swings are also influenced by its low float and sector momentum, particularly related to Bitcoin's movements. Some traders are wary of a potential offering and the company's compliance with listing requirements.

Direxion Shares ETF Trust - Direxion Daily S&P 500 Bear -3X Shares

Direxion Daily S&P 500 Bear 3X Shares

SPXS is trending as traders discuss potential market downturns and use it as a leveraged tool for shorting the S&P 500. Community members are debating entry points, hedging strategies, and the possibility of a reverse split, while also reacting to economic news and geopolitical events. Some traders are also expressing frustration with the ETF's performance, especially when the market is trending upwards.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as the aerospace sector gains momentum, potentially fueled by speculation around a SpaceX IPO and renewed interest in space infrastructure. The community is discussing the company's growth potential, upcoming launches, and Neutron rocket development, with some analysts projecting significant upside. Positive sentiment is also emerging related to AI data centers in space, potentially creating further opportunities for Rocket Lab.

FNGU tracks 3x the daily price movements of an index of technology and consumer discretionary companies. The note uses derivatives to achieve its 3x exposure.

Bank of Montreal - MicroSectors FANG+ 3X Leveraged ETNs

Bank of Montreal - BMO REX MicroSectors FANG+ Index 3X Leveraged ETN

FNGU is trending as traders discuss its potential for gains amid positive market sentiment and anticipation of upcoming earnings reports from its major holdings like AVGO and META; some traders are highlighting FNGU's potential to reach new all-time highs, while others are comparing it to other leveraged ETFs like BULZ. Community members are actively sharing bullish perspectives and discussing short-term trading strategies around this leveraged ETF, focusing on key tech companies within the fund.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

Motorola Solutions ($MSI) is trending as analysts release target prices, sparking community interest and options activity. Discussions revolve around analysts' expectations, technical indicators, and the potential for a bullish trend if the stock breaks above key moving averages. Some traders are looking at oversold conditions as a buying opportunity, while others discuss sentiment manipulation and protective put strategies by institutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company closed November with 26.9 million funded customers, about 130,000 fewer than in October.</li><li>Trading activity slowed in several categories, with equity notional volumes falling 37%, options contracts dropping 28% and crypto volumes declining 12%.</li><li>Earlier this week, Robinhood Markets entered the Indonesian market after acquiring brokerage PT Buana Capital Sekuritas and digital asset trader PT Pedagang Aset Kripto.</li></ul>Shares of Robinhood Markets Inc. (HOOD) dropped over 8% on Thursday after a price target cut, triggered by the company’s reported decline in funded customers for November.HOOD stock is on track to decline for a third straight session.Cantor Fitzgerald lowered the firm’s price target on Robinhood to $152 from $155 but kept an ‘Overweight’ rating on the shares. The new target still implies a potential upside of 22% from the current market price of $124.4.The firm noted that Robinhood saw a month-over-month volume decline in November after an unusually strong October, with equities down 37%, options down 28%, and crypto down 12%.<h2 class="st-heading-2">November Volumes Snapshot</h2>The company closed November with 26.9 million funded customers, about 130,000 fewer than in October. Robinhood said the decline was mainly due to the required escheatment of roughly 280,000 low-balance accounts. Excluding that impact, funded customers would have increased by about 150,000 for the month.Total platform assets came in at $325 billion, representing a 5% decrease from October but a 67% increase from last year. Net deposits remained strong at $7.1 billion, representing a 25% annualized growth rate relative to October’s asset base.Trading activity slowed in several categories. Equity notional volumes fell 37% month over month, and options contracts traded dropped 28%. Crypto volumes declined 12% overall, reflecting decreases across both the Robinhood app and Bitstamp. Event contracts stood out as the only growing segment, rising 20% to 3 billion.<h2 class="st-heading-2">Foray Into Indonesia</h2>Earlier this week, Robinhood Markets struck a deal to acquire Indonesian brokerage PT Buana Capital Sekuritas and digital asset trader PT Pedagang Aset Kripto, with the deals expected to close in the first half of 2026.On Wednesday, BofA lowered Robinhood’s target price to $154 from $166 while maintaining a ‘Buy’ rating, noting that alternative asset managers have better valuations and positioning setups than online brokers.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘neutral’ from ‘bearish’ yesterday. HOOD is among the top trending tickers on Stocktwits.One user suggested buying the dip.<stembedurl>https://stocktwits.com/alexCRV/message/638887719</stembedurl>HOOD stock has seen strong buying interest this year, gaining over 220%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/smx-stock-surged-50-today-here-s-all-about-its-breakthrough-pilot-on-tracking-recycled-cotton/cLIx1aSREny">SMX Stock Surged 50% Today – Here’s All About Its Breakthrough Pilot On Tracking Recycled Cotton</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Robinhood logo displayed on a phone screen is seen in this illustration photo taken in Krakow, Poland on June 29, 2021 

HOOD Stock Tumbles After November Volumes Drop – Cantor Slashes Price Target, But It Still Implies Significant Potential Upside

Cantor Fitzgerald lowered the firm’s price target on Robinhood to $152 from $155 but kept an ‘Overweight’ rating on the shares.

Equity

<ul class="summary-bullets"><li>SMX’s test demonstrated that molecular markers remained stable and detectable through shredding, spraying, carding, spinning, fabric formation, and finishing.</li><li>The technology will provide regulators and brands with verifiable evidence of recycled content and fiber origin.</li><li>The stock has been on a remarkable run since unveiling its gold tracking technology last month.</li></ul>Shares of SMX (Security Matters) PLC (SMX) surged 50% on Thursday after the company said its molecular technology can now track recycled cotton.<a href="https://stocktwits.com/symbol/SMX">SMX</a> announced a breakthrough pilot that successfully tracked recycled cotton through every stage of the industrial textile production process. The test demonstrated that SMX’s molecular markers remained stable and detectable through shredding, spraying, carding, spinning, fabric formation, and finishing.The result marks an end-to-end proof that cotton can carry a permanent, machine-readable signature from recycling intake to finished fabric, providing regulators and brands with verifiable evidence of recycled content and fiber origin.The technology comes at a time when markets prepare for mandatory Digital Product Passports in Europe and stricter supply-chain disclosure rules across major economies. By enabling scientific authentication, SMX’s system supports compliance with ESG requirements, preferential tariff programs, and trade frameworks for traceable material inputs.<h2 class="st-heading-2">Tracking Gold, Rare Earth</h2>SMX has been expanding its footprint across metals and critical minerals. Last month, SMX unveiled molecular-level identity markers to track gold, followed by markers for precious metals and rare-earth elements. The technology enables the metals to retain proof of origin through crushing, purification, and high-temperature refining.SMX also signed an equity purchase agreement with Target Capital 1 for $111.5 million. The deal includes a $11.5 million convertible promissory note and gives SMX the option to sell up to $100 million in ordinary shares. The company plans to allocate a portion of the proceeds toward bitcoin or other cryptocurrencies as reserve assets.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits remained ‘extremely bullish’ over the past 24 hours, amid ‘extremely high’ message volumes.<figure class="image"><img style="aspect-ratio:912/91;" src="https://news.stocktwits-cdn.com/SMX_png_a1016e7223.webp" alt="SMX.png" width="912" height="91"><figcaption>SMX's Sentiment Meter and Message Volumes at 12:30 p.m ET on Dec. 11, 2025 | Source: Stocktwits</figcaption></figure>As the stock came off its day’s highs, one Stocktwits user believes it’s time to short it.<stembedurl>https://stocktwits.com/jjnewly27/message/638874538</stembedurl>The company’s reverse stock split at an 8-to-1 ratio took effect on Nov. 18, 2025.Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/crbp-stock-surged-36-pre-market-what-did-its-obesity-treatment-drug-study-reveal/cLIxOoAREnh">CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the SMX (Security Matters) logo is seen displayed on a smartphone screen.

SMX Stock Surged 50% Today – Here’s All About Its Breakthrough Pilot On Tracking Recycled Cotton

SMX announced a breakthrough pilot that successfully tracked recycled cotton through every stage of the industrial textile production process.

<ul class="summary-bullets"><li>Cemtrex said it plans to use the $2 million proceeds for general corporate purposes, including working capital and future acquisitions.</li><li>The company signed an LOI to acquire a Tennessee-based industrial services provider.</li><li>CETX is on track for a third consecutive session of decline after surging nearly 130% on Monday.</li></ul>Cemtrex (CETX) stock fell 16% on Thursday after the company announced a $2 million share sale agreement and provided updates on its M&amp;A strategy.<a href="https://stocktwits.com/symbol/CETX">CETX</a> is on track for a third consecutive session of decline after surging nearly 130% on Monday.<h2 class="st-heading-2">Share Sale Agreement</h2>Cemtrex announced a definitive agreement to sell 666,667 shares to a single institutional investor at $3 per share, with expected gross proceeds of $2 million. This is below its current trading price of $3.50.The company said it plans to use the funds for general corporate purposes, including working capital and future acquisitions, as it advances a multi-year plan to improve margins, scale operations, and strengthen long-term earnings prospects.<h2 class="st-heading-2">Update On Acquisitions</h2>The company also reported progress on its acquisition strategy, highlighting the near completion of its purchase of a Texas-based aerospace and defense engineering firm. This deal is expected to expand Cemtrex’s technological capabilities and contribute to operating income beginning in fiscal 2026.After deciding not to pursue a robotics integration firm due to updated financial visibility, the company signed a new letter of Intent (LOI) to acquire a Tennessee-based industrial services provider, with closing targeted for the first quarter of 2026. Cemtrex added that it continues to prioritize profitability and is tightly managing its cost structure.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the decline over the past three sessions, retail sentiment on Stocktwits remained ‘extremely bullish’ over the past 24 hours, amid ‘extremely high’ message volumes.<figure class="image"><img style="aspect-ratio:912/90;" src="https://news.stocktwits-cdn.com/CETX_png_8ae4568f1d.webp" alt="CETX.png" width="912" height="90"><figcaption>CETX's Sentiment Meter and Message Volumes on Dec. 11, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user sounded bullish about the company’s 2026 outlook.<stembedurl>https://stocktwits.com/AnnaKan/message/638866153</stembedurl>Cemtrex had undergone a one-for-fifteen reverse stock split on September 29. The stock has lost over 91% of its value this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/rzlt-stock-lost-nearly-90-of-its-value-today-what-did-the-company-s-latest-trial-reveal/cLIxW9kREno">RZLT Stock Lost Nearly 90% Of Its Value Today – What Did The Company’s Latest Trial Reveal?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

06 February 2025, Baden-Württemberg, Rottweil: A candlestick chart is opened in a trading platform on a smartphone. Photo: Silas Stein/dpa

Why Is CETX Stock Falling Today?

Cemtrex is expected to sell around 666,667 shares to a single institutional investor at $3 per share, below the current trading price of about $3.5.

<ul class="summary-bullets"><li>RZLT stock dropped to its lowest level since February 2024.</li><li>The study also missed its key secondary endpoint, the company said.</li><li>Rezolute said that its Phase 3 upLIFT study in tumour-related hyperinsulinism is underway, with topline results expected in the second half of 2026.</li></ul>Shares of Rezolute, Inc. (RZLT) collapsed nearly 90% on Thursday, after the company reported that its Phase 3 sunRIZE trial of ersodetug to treat low blood pressure failed to meet its primary endpoint.Following the decline, <a href="https://stocktwits.com/symbol/RZLT">RZLT</a> stock fell below its 200-day moving average (200-DMA) for the first time since April 2024 and dropped to its lowest level since February 2024, with trading halted just minutes after the opening bell.<figure class="image"><img style="aspect-ratio:1311/867;" src="https://news.stocktwits-cdn.com/RZLT_png_3ccc7478ed.webp" alt="RZLT.png" width="1311" height="867"><figcaption>RZLT 200-DMA | Source: TradingView</figcaption></figure><h2 class="st-heading-2">What Did The Study Show?</h2>Rezolute reported topline Phase 3 sunRIZE results showing that ersodetug failed to meet its primary endpoint in patients with congenital hyperinsulinism, as the treatment did not reduce weekly hypoglycemia events based on self-monitored blood glucose readings.At the highest dose of 10 mg/kg, ersodetug showed a roughly 45% reduction in hypoglycemia events, but this was not statistically significant compared with the placebo group, which saw a 40% improvement.The study also missed its key secondary endpoint, which assessed changes in daily time spent in hypoglycemia through continuous glucose monitoring. Patients on the 10 mg/kg dose experienced about a 25% reduction in time spent in low blood sugar, but this improvement did not differ significantly from placebo, which showed a 5% increase.Despite the lack of efficacy signals, Rezolute said the achieved drug levels were consistent with expectations across all ages, and the overall safety profile was favorable. Two participants experienced severe hypersensitivity reactions that required stopping treatment, but the company noted that the overall incidence of serious allergic reactions was low. The most common side effect was hypertrichosis, a condition that causes temporary hair growth.“We are disappointed that the study did not demonstrate significant improvements in glucose-related endpoints relative to placebo as well as for the patients and families living with congenital HI who urgently need new treatment options. At the same time, there are aspects of the results that merit additional investigation, and we are conducting a thorough evaluation to gain a better understanding of the study outcomes, which will inform our path forward,” said Brian Roberts, Chief Medical Officer of Rezolute.&nbsp;“We intend to meet with FDA under our Breakthrough Therapy Designation to consider next steps for the program.”&nbsp;&nbsp;Rezolute said that its Phase 3 upLIFT study in tumour-related hyperinsulinism is underway, and topline results are expected in the second half of 2026.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday decline, retail sentiment on Stocktwits remained ‘extremely bullish’ over the past 24 hours, accompanied by ‘extremely high’ message volumes.<figure class="image"><img style="aspect-ratio:915/94;" src="https://news.stocktwits-cdn.com/RZLT_png_536276b697.webp" alt="RZLT.png" width="915" height="94"><figcaption>RZLT's Sentiment Meter and Message Volumes at 10:10 a.m. ET on Dec. 11, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user believes the stock is oversold.<stembedurl>https://stocktwits.com/GuyFawkes_EOD/message/638855933</stembedurl>The stock is down over 73% this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/crbp-stock-surged-36-pre-market-what-did-its-obesity-treatment-drug-study-reveal/cLIxOoAREnh">CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ZoomInfo said net revenue retention was stable for the third consecutive quarter. 

RZLT Stock Lost Nearly 90% Of Its Value Today – What Did The Company’s Latest Trial Reveal?

Rezolute said that its Phase 3 sunRIZE trial of ersodetug to treat low blood pressure failed to meet its primary endpoint.

<ul class="summary-bullets"><li>At the time of writing, silver was up 1% at $62.4 an ounce while futures for March 2026 deliveries jumped 2.5% to $62.56 per ounce.</li><li>Silver prices are likely to remain highly volatile as long as uncertainty over U.S. tariffs persists, a Goldman Sachs analyst told Forbes.</li><li>DXY declined 0.3% to 98.32, marking its lowest level since October 17.</li></ul>Spot silver (XAG/USD) prices jumped to a record high of $62.9 per ounce on Thursday, a day after the U.S. Federal Reserve announced the much-anticipated 25 basis point rate cut.At the time of writing, silver pared some early gains to trade 1% higher at $62.4 per ounce. Silver futures for March 2026 deliveries jumped 2.5% to $62.56 per ounce.<figure class="image"><img style="aspect-ratio:1309/859;" src="https://news.stocktwits-cdn.com/Silver_gold_png_32a5cf5d46.webp" alt="Silver, gold.png" width="1309" height="859"><figcaption>Spot Silver and Gold Prices | Source: TradingView</figcaption></figure><h2 class="st-heading-2">What’s Next For Silver?</h2>The precious metal has been on a historic run. Silver has hit fresh peaks in seven of the last 10 sessions. Daan Struyven, co-head of global commodities research at Goldman Sachs, told Forbes on Thursday that silver prices are likely to remain highly volatile as long as uncertainty over U.S. tariffs persists. Struyven also pointed to a physical squeeze in the London silver market, with inventories low as metal is being shipped to the U.S. amid tariff concerns.He said that many of the factors lifting gold, such as expectations of lower interest rates, also help silver by boosting investor demand. However, unlike gold, silver doesn’t have central bank buying as support, and it tends to be more volatile.Struyven noted that Gold ETFs are roughly 70 times smaller than the U.S. Treasury market, and silver is about nine times smaller than gold, and because of this, even modest flows into silver could drive significant gains.Meanwhile, veteran commodities expert and Head of Commodity Strategy at Saxo Bank, Ole Hansen, noted that silver could see profit-taking as risk sentiment weakened across equities.In a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/Ole_S_Hansen/status/1999015507278672209">post</a> on X, Hansen noted that the firm rejection, partly due to overbought conditions, may signal a shift in focus toward consolidation, with $59 as a major support level.<img src="https://news.stocktwits-cdn.com/Ole_Hansen_png_6e56b6f601.webp" alt="Ole Hansen.png"><h2 class="st-heading-2">Gold And Greenback</h2>Spot gold prices fell 0.2% to $4,219 an ounce, while gold futures for February 2026 deliveries climbed 0.6% to $4,249.2.Meanwhile, the dollar index (DXY) declined 0.3% to 98.32, its lowest level since October 17.<figure class="image"><img style="aspect-ratio:1299/876;" src="https://news.stocktwits-cdn.com/DXY_png_783fa1b935.webp" alt="DXY.png" width="1299" height="876"><figcaption>DXY on Dec. 10, 2025 | Source: TradingView</figcaption></figure>Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/crbp-stock-surged-36-pre-market-what-did-its-obesity-treatment-drug-study-reveal/cLIxOoAREnh">CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Adding SilverCrest’s Las Chispas mine in Mexico is projected to bolster Coeur’s production portfolio.

Spot Silver Continues Hitting Fresh Highs – But This Analyst Warns Of Potential Consolidation

Spot silver prices jumped to a record high of $62.9 per ounce on Thursday, a day after the U.S. Federal Reserve announced the much-anticipated 25 basis point rate cut.

<ul class="summary-bullets"><li>CRB-913 is an oral small-molecule inverse agonist targeting the CB1 receptor, a known pathway for weight loss.</li><li>The study showed that participants reported reductions in food-related thoughts and cravings</li><li>Corbus has initiated a Phase 1b dose-finding study, CANYON-1, in people with obesity, with completion expected by summer 2026.</li></ul>Shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) surged 36% in premarket trading on Thursday after the company announced encouraging Phase 1a results for CRB-913, an oral CB1 inverse agonist targeting chronic obesity.At the time of writing, <a href="https://stocktwits.com/symbol/CRBP">CRBP</a> was among the top trending tickers on Stocktwits.<h2 class="st-heading-2">Results Of The Study</h2>Corbus Pharma said that the single-and multiple-ascending dose study showed that CRB-913 was safe and well-tolerated across all doses, with no serious treatment-emergent adverse events reported. Gastrointestinal issues were minimal, and daily neuropsychiatric assessments remained negative, indicating no signs of suicidality, depression, or anxiety.Participants reported reductions in food-related thoughts and cravings, highlighting early behavioral effects alongside weight reduction. Pharmacokinetic analysis confirmed that CRB-913 is suitable for once-daily oral dosing.Building on the early results, Corbus has initiated a Phase 1b dose-finding study, CANYON-1, in people with obesity, with completion expected by summer 2026. This next stage will further explore optimal dosing and continue evaluating safety, tolerability, and efficacy over a longer period.CRB-913 is an oral small-molecule inverse agonist targeting the CB1 receptor, a known pathway for weight loss. Unlike earlier drugs in this class that raised neuropsychiatric safety concerns, CRB-913 is designed for limited brain penetration to reduce those risks.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment flipped to ‘extremely’ bullish from ‘neutral’ a day earlier, accompanied by ‘extremely high’ message volumes.One user expressed optimism about the CANYON-1 study.<stembedurl>https://stocktwits.com/LuigiDurante/message/638840548</stembedurl>Year-to-date, the stock has declined nearly 15%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/msft-stock-appears-set-to-retest-200-dma-last-time-it-did-its-rebound-didn-t-endure/cLIxBZBREnI">MSFT Stock Appears Set To Retest 200-DMA – Last Time It Did, Its Rebound Didn’t Endure</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal?

Corbus Pharmaceuticals said its Phase 1a study showed CRB-913 was safe and well-tolerated at all doses, with no serious adverse events reported.

<ul class="summary-bullets"><li>Microsoft has announced multi-billion dollar investments in the U.A.E., Portugal, India, and Canada.</li><li>On a YTD basis, MSFT stock has outperformed AAPL and AMZN in the ‘Mag 7’ pack.</li><li>DA Davidson’s Gil Luria was bullish, citing Microsoft’s top position in OpenAI spending as key to its growth as a hyperscaler.</li></ul>Microsoft Corp. (MSFT) stock appears set to retest&nbsp;its 200-day moving average after nudging it once in late November, as the stock has faced resistance near the $492 mark in the last few weeks.<figure class="image"><img style="aspect-ratio:1311/861;" src="https://news.stocktwits-cdn.com/MSFT_png_8b3de6a9f6.webp" alt="MSFT.png" width="1311" height="861"><figcaption>MSFT's 200-DMA on Dec. 11, 2025 | Source: TradingView</figcaption></figure>Ever since late October,&nbsp;<a href="https://stocktwits.com/symbol/MSFT">MSFT stock</a> has been in a corrective mode, dropping from its high around $553 following the first quarter earnings.Despite an upbeat revenue and earnings print, MSFT stock witnessed some pressure after finance chief Amy Hood signaled that capital spending will accelerate this fiscal year. While November’s rebound helped restore some confidence, the key question now is whether the stock can hold its support level in the coming days.<h2 class="st-heading-2">Q1 Results Show Cloud Momentum</h2>Microsoft's first-quarter results surpassed Wall Street’s expectations on both revenue and earnings, thanks to ongoing momentum in its cloud business. The company reported an earnings per share (EPS) of $3.72 on revenue of $77.7 billion, compared to $3.30 EPS and $65.6 billion last year.&nbsp;Commercial cloud revenue rose 26% to $49.1 billion, with Intelligent Cloud, including Azure, contributing $30.9 billion and beating analyst estimates.Still, costs climbed sharply, with capital expenditures surging 74% to $34.9 billion, driven largely by heavy investment in GPUs and CPUs to meet growing AI-related demand.However, JPMorgan, Citi, Wells Fargo, and Morgan Stanley raised their target prices for the stock, citing strong Azure growth and elevated booking metrics.<h2 class="st-heading-2">AI Investment Spree</h2>Microsoft announced investments totaling more than $7.9 billion in the U.A.E., including more than $5.5 billion to expand AI and cloud infrastructure. This is part of a broader $15.2 billion AI initiative in the country.Last month, the software giant announced investments of $10 billion in AI infrastructure at a data center in&nbsp; Portugal, marking one of Europe’s largest AI investment projects. The company will partner with Start Campus, Nscale, and NVIDIA to deploy 12,600 next-generation NVIDIA GPUs at the site.It is also reportedly expanding its global data-center push, including plans for an AI “super factory” comprising two-story facilities in Atlanta, and a commitment of up to $5 billion to Anthropic.Earlier this week, Microsoft announced $23 billion in new AI investments, earmarking $17.5 billion for India starting in 2026 and over C$7.5 billion ($5.42 billion) in Canada over the next two years to expand its cloud capacity.Analysts remain bullish on Microsoft’s AI strategy. DA Davidson’s Gil Luria reiterated a ‘Buy’ rating last week, noting that Microsoft’s leading position in OpenAI spending should maintain its status as the fastest-growing hyperscaler.&nbsp;<h2 class="st-heading-2">The ‘Magnificent 7’ Comparison</h2>Despite MSFT stock’s recent downturn, its year-to-date gains hold above 12%. This is almost similar to Apple’s (AAPL) 12% gains in the same period. Amazon.com Inc. (AMZN) has recorded 4% gains while Tesla (TSLA) has risen over 15%. Nvidia (NVDA) and Google-parent Alphabet Inc. (GOOG, GOOGL) have been the standout stocks this year, soaring more than 35% and 67%, respectively.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘bullish’ from ‘neutral’ a day earlier, accompanied by ‘high’ message volumes.One Stocktwits user was skeptical about the stock’s technicals.<stembedurl>https://stocktwits.com/theoptionsplug/message/638808977</stembedurl>However, another sees a potential upward trend.<stembedurl>https://stocktwits.com/Foster_Todd_29/message/638794547</stembedurl>&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/china-to-reportedly-restrict-nvidia-h200-chip-use/cLIruVQREZO">China To Reportedly Restrict Nvidia H200 Chip Use</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration the Microsoft logo is displayed on a mobile phone screen in Ankara, Turkiye on October 11, 2025.

MSFT Stock Appears Set To Retest 200-DMA – Last Time It Did, Its Rebound Didn’t Endure

Ever since late October, MSFT stock has been in a corrective mode, dropping from its high around $553 following the first quarter earnings.

<ul class="summary-bullets"><li>The company also decided to suspend its quarterly cash dividend on common stock.</li><li>Lakeland said its weak quarter was driven by broad macro pressures, including tariffs, freight and raw-material inflation.</li><li>Q3 net sales of $47.6 million, fell significantly short of Street estimates of $56.7 million.</li></ul>Shares of Lakeland Industries (LAKE) plunged 40% to their lowest level since July 2016 after a downbeat third-quarter report, prompting the company to withdraw both its FY26 guidance and dividend distribution.Net sales for the third quarter of fiscal 2026 rose 4% to $47.6 million, up from $45.8 million a year earlier. However, it fell significantly short of Street estimates of $56.7 million. The company also posted a $16 million loss, compared with a $0.1 million profit last year. Organic gross margin decreased to 32.3% from 42.9%.<h2 class="st-heading-2">Withdrawing FY26 Guidance and Suspending Dividend</h2><a href="https://stocktwits.com/symbol/LAKE">Lakeland</a> said its weak quarter was driven by broad macro pressures, including tariffs, freight and raw-material inflation, that weighed on revenue and margins across the U.S., Canada, Latin America and parts of EMEA. At the same time, acquired businesses also underperformed due to certification delays and material-flow issues.The company emphasized that these problems are fixable rather than demand-related, but the uncertainty has impaired its visibility, prompting Lakeland to withdraw its FY2026 guidance and halt future forecasts.“We missed our targets across multiple areas. And as CEO, I take full responsibility for that performance. Our forecasting has not been reliable and the gap between our internal expectations and actual results has grown too large. Because of this, we will be withdrawing formal guidance,” said CEO Jim Jenkins, in a call with analysts.J. Calven Swinea, Vice President of Finance at Lakeland, stated on the same call that given near-term headwinds and to manage cash prudently, the company has decided to suspend its quarterly cash dividend on common stock.&nbsp;“We believe reinvesting profits into growth opportunities, such as acquisitions,” Swinea said.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the significant intraday decline, retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier, accompanied by ‘extremely high’ message volumes.<figure class="image"><img style="aspect-ratio:916/90;" src="https://news.stocktwits-cdn.com/Lakeland_png_94d790d0d7.webp" alt="Lakeland.png" width="916" height="90"><figcaption>Sentiment Meter and Message Volumes at 12:40 p.m. ET on Dec. 10, 2025 | Source: Stocktwits</figcaption></figure>One user believes the drop may have been overdone.<stembedurl>https://stocktwits.com/msoi/message/638725356</stembedurl>Year-to-date, the stock has declined 65%.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/gev-stock-soars-to-all-time-high-as-wall-street-cheers-massive-upgrade-and-rare-earth-stockpile-plan/cLIHIpcREVk">GEV Stock Soars To All-Time High As Wall Street Cheers Massive Upgrade And Rare Earth Stockpile Plan</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of stock price falling.

LAKE Stock Tanked 40% Today To Hit 9-Year Lows – What Caused The Meltdown?

Lakeland’s stock fell to its lowest since July 2016 after it reported a weak third-quarter print and withdrew FY2026 guidance.

<ul class="summary-bullets"><li>Photronics Q4 revenue of $215.8 million exceeded Street estimates of $204.5 million.</li><li>Non-GAAP EPS came in at $0.6, above estimates of $0.45.</li><li>Photronics expects Q1fiscal 2026 revenue between $217 million and $225 million.</li></ul>Shares of Photronics Inc. (PLAB) surged over 40% on Wednesday, their highest level since March 2001, after the company posted a better-than-expected fourth quarter print.At the time of writing, <a href="https://stocktwits.com/symbol/PLAB">PLAB</a> was among the top trending tickers on Stocktwits.<h2 class="st-heading-2">Earnings Top Estimates</h2>In the fourth quarter, Photronics posted revenue of $215.8 million, down 3.1% year-over-year but above analysts’ estimates of $204.5 million, according to Fiscal.ai. Net income on a GAAP basis jumped to $61.8 million, or $1.07 per share, while non-GAAP net income came in at $34.6 million, or $0.60 per share, marginally above last year’s earnings of $0.59 per share. Analysts had expected an earnings per share of $0.45.Revenue from the company’s Integrated Circuit (IC) segment fell 4% to $157.4 million, but grew 7% sequentially. Revenue from its flat panel display (FPD) declined 1% to $58.3 million. The company ended the quarter with $588.2 million in cash and short-term investments.Looking ahead, Photronics expects first-quarter fiscal 2026 revenue of $217 million to $225 million, which is above the $212.1 million it posted in Q1 of fiscal 2025. The company expects non-GAAP net income of $0.51 to $0.59 per share, compared to its Q1 FY25 EPS of $0.52.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits remained in the ‘extremely bullish’ territory over the past 24 hours, accompanied by ‘extremely high’ message volumes.<figure class="image"><img style="aspect-ratio:912/88;" src="https://news.stocktwits-cdn.com/PLAB_png_d09015e2ac.webp" alt="PLAB.png" width="912" height="88"><figcaption>PLAB's Sentiment Meter and Message Volumes at 12:05 p.m. ET on Dec. 10, 2025 | Source: Stocktwits</figcaption></figure>One user expects the stock to see further gains before the market closes.<stembedurl>https://stocktwits.com/ryno8316/message/638729380</stembedurl>Another user sees room for gains due to the stock’s low valuation.<stembedurl>https://stocktwits.com/T7_Hldg_Partner/message/638726974</stembedurl>Year-to-date, the stock has gained more than 45%.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/gev-stock-soars-to-all-time-high-as-wall-street-cheers-massive-upgrade-and-rare-earth-stockpile-plan/cLIHIpcREVk">GEV Stock Soars To All-Time High As Wall Street Cheers Massive Upgrade And Rare Earth Stockpile Plan</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising chart and reflection of business buildings: stock photo courtesy of Yuichiro Chino via Getty Images

Why Did PLAB Stock Surge To A 24-Year High?

Photronics surged over 40% to a 24-year high on Wednesday, after the company posted a better-than-expected fourth quarter print.

<ul class="summary-bullets"><li>GE Vernova is working with the U.S. government to expand stockpiles of yttrium, a critical rare earth metal, Reuters reported.</li><li>The company increased its share repurchase authorization to $10 billion from $6 billion.</li><li>JPMorgan raised GE Vernova’s target price to $1,000 from $740 and maintained an ‘Overweight’ rating.</li></ul>Shares of GE Vernova Inc. (GEV) jumped as much as 17% to a record high on Wednesday after the company raised its FY2028 revenue and adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin targets, while also revealing that it is working with the U.S. government to boost rare earth stockpiles.<a href="https://stocktwits.com/symbol/GEV">GEV</a> was among the top-trending tickers on Stocktwits on Wednesday morning.<h2 class="st-heading-2">2028 Revenue Guidance</h2>At its 2025 Investor Update in New York, GE Vernova raised its long-term financial targets, highlighting what CEO Scott Strazik called “the early chapters of an incredible value-creation opportunity.”The company now expects revenue to reach $52 billion by 2028, up from its earlier forecast of $45 billion, along with a significantly higher EBITDA margin of 20%. GE Vernova also anticipates generating at least $22 billion in cumulative free cash flow from 2025 to 2028, well above its prior expectations of $14 billion.The company reaffirmed its 2025 financial guidance and introduced 2026 forecasts, calling for up to $42 billion in revenue next year and adjusted EBITDA margins of up to 13%. The Board also doubled the quarterly dividend to $0.50 per share and increased the share repurchase authorization to $10 billion from $6 billion.<h2 class="st-heading-2">Expanding Yttrium Stockpiles</h2>GE Vernova is working with the U.S. government to expand stockpiles of yttrium, a critical rare earth metal facing severe global shortages, according to a Reuters report on Wednesday. Strazik said the company has secured enough yttrium to last through 2025 and into 2026, but is continuing to build inventory as China’s export restrictions tighten supplies for the energy, aerospace, and semiconductor sectors.<h2 class="st-heading-2">What Did Analysts Say?</h2>JPMorgan raised GE Vernova’s target price to $1,000 from $740 and maintained an ‘Overweight’ rating, according to TheFly. The company’s “by 2028” financial targets were stronger than expected for the core Power and Electrification segments, with multiple paths to upside. GE Vernova's Power order activity in Q4 significantly exceeded expectations, JPMorgan added.RBC Capital upgraded GE Vernova to ‘Outperform’ from ‘Sector Perform’ and lifted its price target to $761 from $630, citing the company’s strengthened medium-term outlook. In a note to investors, the firm said its earlier downgrade underestimated GE Vernova’s accelerating growth and margin potential, which continue to improve through stronger equipment margins and ongoing productivity gains.&nbsp;RBC added that the stock’s recent multiple expansion signals growing confidence that earnings estimates may continue to move higher.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘neutral’ a day earlier, accompanied by ‘extremely high’ message volumes.<figure class="image"><img style="aspect-ratio:927/97;" src="https://news.stocktwits-cdn.com/GEV_png_34100a05f7.webp" alt="GEV.png" width="927" height="97"><figcaption>GEV's Sentiment Meter and Message Volumes at 10:35 a.m. ET on Dec. 10, 2025 | Source: Stocktwits</figcaption></figure>One user highlighted the company’s growth.<stembedurl>https://stocktwits.com/mikesterz7/message/638718086</stembedurl>Year-to-date, the stock has gained more than 115%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/silver-price-surges-to-fresh-highs-ahead-of-fed-decision-later-today/cLIHI9IREVL">Silver Price Surges To Fresh Highs Ahead Of Fed Decision Later Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the GE Vernova company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

GEV Stock Soars To All-Time High As Wall Street Cheers Massive Upgrade And Rare Earth Stockpile Plan

GE Vernova expects revenue to reach $52 billion by 2028, up from its earlier forecast of $45 billion, along with a higher adjusted EBITDA margin of 20%.